# Mirum Pharmaceuticals, Inc.: Form 8-K, filed Sep 8, 2026

- Company: [Mirum Pharmaceuticals, Inc.](/companies/mirm.md) (CIK 1759425)
- Form: 8-K
- Filed: 2026-09-08
- Accepted by EDGAR: Sep 8, 2026, 08:34 ET
- Period: 2026-09-02
- Accession: 0001759425-26-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/mirm-20260902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/mirm-20260902.htm

Filed Sep 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001759425-26-000047. Last ingested by Listed: Nov 14, 2026, 22:38 ET. No prices; not investment advice.
